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FAK and paxillin are important components in integrin-
regulated signaling. New evidence suggests that these two
proteins function in crosstalk between cell–matrix and
cell–cell adhesions. Further, new insight suggests that under
some conditions these proteins inhibit cell migration, in
contrast to their established roles in several cell systems as
positive regulators of cell adhesion and migration.
 
FAK and paxillin are two focal adhesion–associated proteins
that function in transmitting signals downstream of inte-
grins. These signals control important biological events, in-
cluding cell migration, proliferation, and survival. Yano et
al. (2004) now report intriguing findings that may stimulate
reevaluation of the role of FAK and paxillin in the regulation
of cell motility. Using a small interfering RNA (siRNA)
strategy, FAK and paxillin signaling was impaired, resulting
in increased cell migration and suggesting these proteins
normally function to retard motility. This observation will
prove controversial, as many reports have implicated FAK as
a positive regulator of cell motility, and several reports have
demonstrated a similar function for paxillin. In addition,
siRNA-mediated knockdown of FAK and paxillin resulted
in impaired assembly of N-cadherin–containing cell–cell ad-
hesions, suggesting a novel role for these proteins in the
crosstalk between cell–matrix and cell–cell adhesions.
Given the plethora of evidence implicating FAK as a posi-
tive regulator of cell migration, how can the discrepant re-
sults presented by Yano et al. (2004) be resolved with the lit-
erature? The contradictory results are not simply explained
by cell type differences, as inhibition of FAK and paxillin by
siRNA impairs motility in both HeLa cells (of epithelial ori-
gin) and human fibroblasts. The use of collagen as a matrix
for migration in this report could contribute to the differ-
ence in phenotype. On collagen, cells treated with FAK and
paxillin siRNAs exhibit smaller focal adhesions and a protru-
sive morphology (Yano et al., 2004), phenotypes that are
distinct from those described for the 
 
fak
 
 
 
/
 
 
 
 and 
 
paxillin
 
 
 
/
 
 
 
fibroblasts (Ilic et al., 1995; Hagel et al., 2002), albeit many
analyses of these fibroblasts use fibronectin for adhesion.
Notably, despite the enhanced extension of protrusions,
HeLa cells with reduced FAK and paxillin are not highly po-
larized, and therefore might exhibit defects in directional
migration. Thus, measuring random migration, as was done
by Yano et al. (2004), could contribute to the unanticipated
outcome of these new experiments because most reports im-
plicating FAK as a positive regulator of migration have ex-
amined directional motility in response to chemotactic or
haptotactic gradients (Ilic et al., 1995; Sieg et al., 2000).
Although several reports implicate paxillin as a positive
regulator of motility (Hagel et al., 2002), overexpression of
paxillin in several cell types is reported to impair haptotaxis
(Yano et al., 2000). Interestingly, collagen was used as the
haptotactic stimulus in this paper. In contrast to the results
seen with inhibition of FAK and paxillin expression by
siRNA, inhibition of p130cas, another focal adhesion–asso-
ciated FAK-binding partner linked to promotion of migra-
tion (O’Neill et al., 2000), had no effect on migration, mor-
phology, or formation of N-cadherin–containing adhesions
(Yano et al., 2004). Hence, as described in this paper, a sub-
set of focal adhesion–associated proteins are involved in the
generation of this phenotype, possibly reflecting different
roles for different FAK-containing complexes in the regula-
tion of cell migration.
What is the mechanism through which FAK and paxillin
inhibit motility and protrusion, and promote the formation
of N-cadherin–containing adhesions? The phenotypes pro-
duced by inhibition of FAK and paxillin are reversed by co-
expression of a dominant-negative Rac1 mutant and mim-
icked by expression of constitutively active Rac1, suggesting
that FAK and paxillin may normally function in these sce-
narios to attenuate Rac1 signaling (Yano et al., 2004). Al-
though there is no global change in the level of Rac1 activity
in cells with reduced FAK or paxillin expression, experi-
ments using a FRET-based Rac biosensor suggest local in-
creases in activity in these cells, particularly at the periphery
and at areas of cell–cell contact (Yano et al., 2004). How
FAK might inhibit Rac1 activity is not clear, as previous pa-
pers suggest that FAK promotes Rac1 activation through a
p130cas–Crk–Dock180 complex or potentially a paxillin–
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Crk–Dock180 complex (Hsia et al., 2003). Although FAK
might recruit other proteins to directly target inactivation of
Rac1 (e.g., a RacGAP), FAK might also indirectly impair ac-
tivation of Rac1 by inhibiting a distinct signaling pathway
that stimulates Rac1 activity (Fig. 1 A). Paxillin could sim-
ply function in regulating FAK localization as proposed
(Yano et al., 2004), or paxillin could play a more direct role
in regulation of Rac1 by recruiting a regulatory complex
comprised of PKL, PIX, and PAK. Support for this latter
mechanism comes from reports expressing paxillin mutants
in CHO cells. Expression of a paxillin mutant that fails to
associate with PKL produced a protrusive cellular morphol-
ogy and elevated levels of active Rac1 after cell adhesion
(West et al., 2001). In addition, this mutant caused in-
creased random motility on fibronectin, but reduced rates of
directional motility in a wound-healing assay. The similarity
in phenotype induced by expression of this mutant and inhi-
bition of paxillin by siRNA validates PKL and associates as
candidates for negative regulation of motility by paxillin.
Tyrosine 861, a site of Src-dependent phosphorylation on
FAK, was implicated in retarding motility (Yano et al.,
2004). Phosphorylation of this site could regulate interac-
tions with binding partners that function to inactivate Rac1
signaling, or alternatively, might contribute to localization
or spatially regulated activation of FAK signaling (e.g., at the
cell periphery), providing a mechanism for regulating bio-
chemical events in a spatial manner (Fig. 1 B). VEGF-stimu-
lated phosphorylation of tyrosine 861 promotes association
of FAK with 
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5 integrins in endothelial cells (Eliceiri et
al., 2002). Although 
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5 may not be relevant to the cur-
rent paper, this finding presents an interesting paradigm for
a mechanism regulating FAK function in a spatial fashion.
Another intriguing observation was the impaired recruit-
ment of N-cadherin to sites of cell–cell contact when cells
with reduced FAK/paxillin expression were plated at low den-
sity, although these cells could form N-cadherin–containing
contacts when plated at high density. Further, FAK/paxillin
was required for the maintenance of N-cadherin–containing
cell–cell contacts in cells at the edge of wounds introduced
into confluent monolayers. A local reduction in Rac1 activity
at the region of cell–cell contact, which requires FAK and pax-
illin, may control the recruitment/maintenance of N-cadherin
at these sites. The function of Rac1 at sites of cell–cell adhe-
sion is complex. Although engagement of cell surface E-cad-
herin can stimulate activation of Rac1 (for review see Yap and
Kovacs, 2003), engagement of N-cadherin is reported to re-
duce the activity of Rac1 (Charrasse et al., 2002). In a number
of cases, Rac1 signaling is required for the assembly of cad-
herin into cell–cell adhesions. In keratinocytes, constitutively
active Rac1 and dominant-negative Rac1, which functions to
block endogenous Rac1, can produce the same phenotype,
loss of E-cadherin from sites of cell–cell contact (Braga et al.,
1999, 2000). In this scenario, the appropriate level of Rac1
activity is required for assembly and maintenance of E-cad-
herin–containing junctions. Intriguingly, different extracellu-
lar matrices can modulate the biological consequences of Rac
activation by Tiam1, a guanine nucleotide exchange factor for
Rac. On fibronectin and laminin Tiam1 promoted cell–cell
adhesions in MDCK cells, whereas the same cells exhibited a
motile phenotype when plated on collagen (Sander et al.,
1998). As the N-cadherin analyses reported by Yano et al.
(2004) were performed on collagen, the latter paradigm may
be relevant given the correlation of elevated Rac1 activity at
sites of cell–cell contact and the failure to assemble N-cad-
herin–containing junctions. At these sites, FAK and paxillin
may function to initially reduce the level of Rac1 activity, but
upon establishing homophilic interactions between N-cad-
herins on adjacent cells, it is likely that N-cadherin–mediated
signaling also functions in dampening Rac1 activity in these
regions of the cell (Fig. 1 C).
Figure 1. Regulation of Rac activity by FAK paxillin. (A) FAK/p130cas stimulates Rac activation, whereas FAK/paxillin may inhibit Rac activity. 
This may occur via direct targeting of Rac by FAK/paxillin-associated regulators of Rac (1). Alternatively, FAK/paxillin signaling may interfere 
via crosstalk with a distinct signaling pathway (X) that promotes Rac activation (2). (B) In this schematic of the edge of a cell, peripheral Rac activity 
is low (red), whereas nonperipheral Rac activity is high (green). At the periphery, FAK/paxillin may function to reduce Rac activity. This could 
be achieved by discrete relocalization of FAK/paxillin or spatially dependent modulation of the Rac-inhibiting activity of FAK/paxillin. (C) In 
this schematic of two cells in contact, FAK/paxillin signaling and N-cadherin signaling may both contribute to the reduced levels of active Rac 
near cell–cell junctions. 
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The Yano et al. (2004) paper is provocative for a number
of reasons. It defines a novel role for FAK and paxillin in
controlling the assembly of N-cadherin contacts. It also sug-
gests FAK and paxillin may function in inhibiting cell motil-
ity in addition to their established functions in promoting
migration. It is quite interesting that the same regulatory
molecules could positively and negatively control migration
in different contexts. Clearly, elucidation of the conditions
dictating positive or negative regulation and the mechanism
of action in these two scenarios will be high priorities in the
near future.
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